JPH07277996A - Method for soothing inflammation of mastitis in ungulata and antiinflammatory solution - Google Patents

Method for soothing inflammation of mastitis in ungulata and antiinflammatory solution

Info

Publication number
JPH07277996A
JPH07277996A JP8920594A JP8920594A JPH07277996A JP H07277996 A JPH07277996 A JP H07277996A JP 8920594 A JP8920594 A JP 8920594A JP 8920594 A JP8920594 A JP 8920594A JP H07277996 A JPH07277996 A JP H07277996A
Authority
JP
Japan
Prior art keywords
mastitis
solution
inflammatory solution
bacteria
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8920594A
Other languages
Japanese (ja)
Other versions
JP3680125B2 (en
Inventor
Kunichi Noguchi
勲一 野口
Masayuki Ukon
雅幸 右近
Kumiko Onuki
久美子 大貫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NIPPON INTEC KK
Original Assignee
NIPPON INTEC KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NIPPON INTEC KK filed Critical NIPPON INTEC KK
Priority to JP08920594A priority Critical patent/JP3680125B2/en
Publication of JPH07277996A publication Critical patent/JPH07277996A/en
Application granted granted Critical
Publication of JP3680125B2 publication Critical patent/JP3680125B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00Treatment of water, waste water, or sewage
    • C02F1/46Treatment of water, waste water, or sewage by electrochemical methods
    • C02F1/461Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
    • C02F1/46104Devices therefor; Their operating or servicing
    • C02F1/4618Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
    • CCHEMISTRY; METALLURGY
    • C02TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02FTREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F2303/00Specific treatment goals
    • C02F2303/04Disinfection

Abstract

PURPOSE:To wet the sites infected with bacteria in the udders of Ungulata animal and eradicate the pyogenic bacteria to soothe the inflammation by injecting oxidation potential water from nipples through the ducts into the glands in a prescribed amount. CONSTITUTION:The udder of Ungulata animal which has already caused mastitis and has stiffness therein is injected with oxidation potential water of 2.6pH and 1,080mV ORP from the corresponding nipple in an amount of 500-600ml twice a day in the morning and evening for 20 to 30 minutes. Then, the injected solution is squeezed out as in milking and then the new oxidation potential solution of 2.6pH and 1080mV ORP is injected into the udder again. The same operations are repeated for two days to loosen the udder stiffness and after three days, there is found no anomaly from bacteriological point of view and the number of cell in the milk was restored to the normal level.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は有蹄類の家畜、特に牛な
どの乳房などの乳房炎を鎮炎する鎮炎液に関するもので
ある。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an anti-inflammatory solution for suppressing mastitis such as udder of ungulates, especially cows.

【0002】[0002]

【従来の技術】家畜を取り巻く環境および取扱に伴っ
て、家畜が常在細菌による自発性感染症や化膿菌に感染
する場合がある。例えば、乳牛などでは臥した状態で、
乳頭や乳房が細菌に汚染された牧草や飼料などと接触す
る虞れがあり、また、搾乳の際、乳頭や搾乳器が不潔で
あると化膿菌が乳頭から乳房に感染する。また、不注意
に乳房炎に感染した乳頭を拭いた繊維などを未感染の乳
牛の乳頭に触れると感染し乳房炎を多発させる。乳牛に
乳房炎が発生すると、乳房にしこりなどの症状がでて発
熱し、乳牛を衰弱させ乳出量が少なくなるのみならず、
細胞数が30万を超す場合、牛乳は飲料に不適となる。
更に炎症が拡大すると乳牛として使用不可能になり廃牛
せざるを得ない事態となり経済的に損失を被る。また、
上記の炎症の回復が遅れる場合は長期に亘って搾乳でき
ないので、酪農経営にとって計り知れない打撃となる。
2. Description of the Related Art Due to the environment surrounding livestock and the handling of livestock, livestock may be infected with spontaneous infections caused by indigenous bacteria or Pseudomonas aeruginosa. For example, when you are lying down on a dairy cow,
There is a risk that the teats and breasts will come into contact with bacteria-contaminated grass and feed, and during milking, if the teats and breast pumps are not clean, Pseudomonas aeruginosa will infect the breasts from the teats. Inadvertently touching the teat of an uninfected dairy cow with fibers or the like that wipes the teat infected with mastitis will cause infection and increase mastitis. When mastitis occurs in a dairy cow, symptoms such as a lump in the udder occur and a fever occurs, which not only weakens the dairy cow and reduces the milk output,
If the number of cells exceeds 300,000, milk becomes unsuitable for drinks.
If the inflammation further expands, it becomes unusable as a dairy cow, and the cow must be abandoned, resulting in economic loss. Also,
When the recovery of the inflammation is delayed, milking cannot be performed for a long time, which is an immeasurable impact on dairy farming.

【0003】乳房炎の予防のために、搾乳中の乳頭や乳
房を清浄にするため、湯または水で洗浄後、殺菌消毒剤
などを湿潤した紙、布で乳頭や乳房などを拭きとってい
る。例えば、特開平3−136649号および特開平3
−136650号においては銀、銅などの抗菌性金属分
子を含浸、担持した吸湿性の各種の繊維およびポリアク
リロニトリル−ヨード錯体としてヨードを含むポリアク
リロニトリル繊維を作成して、これで拭き取ることを推
奨している。
In order to prevent mastitis, in order to clean the teats and breasts during milking, they are washed with hot water or water, and then wiped with a paper or cloth moistened with a sterilizing agent. . For example, JP-A-3-136649 and JP-A-3-13649.
In No. 136650, it is recommended to prepare various hygroscopic fibers impregnated with and carry antibacterial metal molecules such as silver and copper and polyacrylonitrile fiber containing iodine as a polyacrylonitrile-iodine complex and wipe it off with it. ing.

【0004】乳房炎が発生した場合、ペニシリンなどの
抗生物質を注入して化膿菌を死滅する方法が採られてい
る。この方法は効果的ではあるが、注入した抗生物質が
継続的に乳房内に存在して搾乳した乳汁に混入、汚染す
る可能性があり乳房炎が鎮炎したからといってすぐに乳
汁を飲料とすることは極めて危険で、炎症が治癒しても
しばらくの間は採取した乳汁を廃棄せざるを得ない。
When mastitis occurs, a method of injecting an antibiotic such as penicillin to kill Pseudomonas aeruginosa is adopted. Although this method is effective, the infused antibiotics may continue to be present in the breast and mix with and contaminate the milk expressed, contaminating milk and drinking milk immediately after the mastitis has subsided. This is extremely dangerous, and even if the inflammation heals, the milk collected must be discarded for a while.

【0005】ペニシリンなどの抗生物質を注入して化膿
菌を死滅する方法では抗生物質の使用に伴って細菌の対
抗性が増し、抗生物質の注入量を暫時増加しなければな
らない。また、飼料に混合して家畜に多様な種類の添加
物が投与されている場合がある。家畜ごとに投与された
添加物の種類によっては固有の耐性菌がつくりだされて
いる可能性があり、前記したペニシリンなどの抗生物質
が継続的にきくとは限らず、適宜抗生物質を変更しなけ
ればならない。
In the method of injecting antibiotics such as penicillin to kill Pseudomonas aeruginosa, the resistance of bacteria increases with the use of antibiotics, and the injection amount of antibiotics must be increased for a while. In addition, various types of additives may be administered to livestock by being mixed with feed. Depending on the type of additive administered to each livestock, a unique resistant bacterium may have been created, and antibiotics such as penicillin described above may not always be heard continuously. There must be.

【0006】水道水等の原水に電解質を一定の割合で添
加して密閉された電解槽に導入し、電解槽内のイオン浸
透性隔膜を介して分離した陰陽極間に直流電流を通電し
て、水の電気分解およびイオン浸透作用を行い、陰極側
には陰極水を、陽極側には陽極水を生成し、陰極水は排
水し、陽極水を殺菌性水として使用する酸化電位水生成
装置がある。
An electrolyte is added to raw water such as tap water in a fixed ratio and introduced into a closed electrolytic cell, and a direct current is applied between the negative and positive electrodes separated via an ion-permeable diaphragm in the electrolytic cell. , Electrolysis of water and ion permeation, producing cathode water on the cathode side, producing anode water on the anode side, draining the cathode water, and using the anode water as sterilizing water. There is.

【0007】酸化電位水は殺菌水として効果がある。し
かも、この酸化電位水には有機殺菌液のような殺菌性の
ある薬剤を投入しないため、有害な物質を含まず、生体
組織に刺激性や毒性を与えない。また、経時と共に酸化
還元電位(以下、ORPという)が低下するため残留性
がなく信頼のできる殺菌水として重宝されている。
Oxidizing potential water is effective as sterilizing water. Moreover, since a sterilizing agent such as an organic sterilizing solution is not added to this oxidizing potential water, it does not contain harmful substances and does not cause irritation or toxicity to living tissues. Further, since the oxidation-reduction potential (hereinafter referred to as ORP) decreases with time, it is useful as sterilizing water that has no residual property and is reliable.

【0008】[0008]

【発明が解決しようとする課題】そこで本発明は、酸化
電位水生成装置から得た酸化電位水を家畜の乳房に注入
して家畜に無害な鎮炎液として鎮炎作用をしようとする
ものである。また、酸化電位水を家畜の乳房洗浄液とし
て使用し、乳房や乳頭表皮を洗浄、殺菌することにより
乳房炎の発生予防と早期治療並びに細菌による表皮の感
染を阻止しようとするものである。
SUMMARY OF THE INVENTION Therefore, the present invention is intended to inject the oxidizing potential water obtained from the oxidizing potential water generator into the breasts of livestock to exert a flame-retarding action as an anti-inflammatory liquid harmless to livestock. is there. Further, the present invention intends to prevent the occurrence and early treatment of mastitis and prevent the infection of the epidermis by bacteria by using the oxidative potential water as a liquid for washing the breast of livestock to wash and sterilize the epidermis of the udder and nipple.

【0009】[0009]

【課題を解決するための手段】前記目的に鑑み本発明
は、電解槽直前に置かれた電解質供給手段から添加され
た電解質を流入し、イオン透過性隔膜で分割され、陰電
極を挿入した陰極室と陽電極を挿入した陽極室との陰陽
電極間に直流電圧を印加し、電解槽の電解強度を可変す
る印加電圧可変手段を設け、電解槽に流入した原水を電
解する装置で生成した陽極水、即ち、酸化電位水を有蹄
類の乳房に注入することにより鎮炎液として乳房炎を鎮
炎する。
In view of the above object, the present invention provides a cathode in which an electrolyte added from an electrolyte supply means placed immediately before an electrolytic cell is introduced and divided by an ion permeable diaphragm and a negative electrode is inserted. Anode generated by a device that electrolyzes the raw water flowing into the electrolytic cell by applying a DC voltage between the positive and negative electrodes of the chamber and the positive and negative electrode in which the positive electrode is inserted, and by varying the applied voltage to vary the electrolytic strength of the electrolytic cell. Mastitis is extinguished as an anti-inflammatory solution by injecting water, that is, oxidation potential water, into the ungulate udder.

【0010】前記乳房への注入は乳頭から注入管をもっ
て注入し、乳線管から筋上皮細胞を逆浸透し、乳線胞へ
と泌乳に逆らって細菌感染患部を湿潤させる。
The injection into the breast is performed by injecting from the nipple with an infusion tube, reversely osmosis myoepithelial cells from the milk duct, and moisten the affected area of bacterial infection against lactation against lactation.

【0011】前記鎮炎液はpH2.5〜3.0、ORP
900〜1100mvである。
The anti-inflammatory solution has a pH of 2.5 to 3.0 and ORP.
It is 900-1100 mv.

【0012】前記鎮炎液はpH2.5〜3.0、ORP
900〜1100mvで、食塩0〜1%を含有すること
を要旨とするものである。
The anti-inflammatory solution has a pH of 2.5 to 3.0 and ORP.
The gist is to contain 0 to 1% of salt at 900 to 1100 mv.

【0013】[0013]

【作用】酸化電位水はウイルスや細菌、真菌等を死滅す
る効果があり、また、血液、体液、膿等の水溶解性物質
に浸透・溶解する性質がある。酸化電位水を乳頭より乳
房の乳線管を介して所定量注入することにより、筋上皮
細胞を逆浸透し、乳線胞へと泌乳に逆らって細菌感染患
部を湿潤させ、化膿菌を死滅させ乳房を鎮炎するもので
ある。
[Function] Oxidizing potential water has the effect of killing viruses, bacteria, fungi and the like, and has the property of penetrating and dissolving in water-soluble substances such as blood, body fluids and pus. By injecting a predetermined amount of oxidative potential water from the nipple through the mammary duct of the breast, reverse osmosis of myoepithelial cells occurs, moisturizes the affected area against bacterial lactation against lactation, and kills Pseudomonas aeruginosa. It extinguishes the breast.

【0014】なお、前記酸化電位水は原水への単位流量
に対する電流量、単位流量に対する電解質の添加量など
によって各種の酸化電位水が得られるが、pH2.5〜
3.0、ORP900〜1100mvを使用すれば殺菌
に効果ある目的とする鎮炎液が得られる。また、所望に
よって鎮炎液に0〜1%程度の食塩を加えて生理食塩型
鎮炎液としても殺ウイルス、殺菌効果は変わらず、筋上
皮細胞の逆浸透に有効である。
Various kinds of oxidation potential water can be obtained depending on the amount of current to the raw water per unit flow rate, the amount of electrolyte added per unit flow rate, etc.
When 3.0 and ORP900-1100mv are used, the target anti-inflammatory solution effective for sterilization can be obtained. Further, if desired, about 0 to 1% of salt is added to the anti-inflammatory solution to obtain a physiological saline-type anti-inflammatory solution, which does not change the virucidal and bactericidal effects and is effective for reverse osmosis of myoepithelial cells.

【0015】前記のようにして生成された鎮炎液はウイ
ルス、細菌および真菌に対して細菌抑止および殺菌効果
を持つ。例えば、下表に示す細菌および真菌に対して効
果を持つ。即ち、表記菌を肉汁培養液で培養し、夫夫の
菌液各0.1mlと洗浄液0.9mlを混和して鎮炎液
濃度として90%とし、室温で3分間処理した後に残存
している菌数をコロニー形成により調べた。結果は表1
に示すように、いずれの菌も完全に不活性化されたこと
が確認される。
The anti-inflammatory solution produced as described above has a bacterial deterrent and bactericidal effect against viruses, bacteria and fungi. For example, it has an effect against bacteria and fungi shown in the table below. That is, the indicated bacteria were cultivated in a broth culture solution, and 0.1 ml each of the bacterium solution of each husband and 0.9 ml of the washing solution were mixed to bring the concentration of the anti-inflammatory solution to 90%, and the mixture remained after being treated at room temperature for 3 minutes. The number of bacteria was examined by colony formation. The results are shown in Table 1.
It is confirmed that all the bacteria were completely inactivated, as shown in.

【表1】 鎮炎液の殺菌効果 細菌、真菌名 生菌数/ml 未処理 3分処理 黄色ブドー球菌 108.3 <100 細菌 大腸菌 109.0 <100 枯草菌 107.4 <100 真菌 キャンデーダ 107.3 <100 [Table 1] Antiseptic solution bactericidal effect Bacteria, fungus Nominal number of bacteria / ml Untreated 3 minutes treated Staphylococcus aureus 108.3 <100 Bacteria E. coli 109.0 <100  Bacillus subtilis 107.4 <100 Fungus candy da 107.3 <100

【0016】また、鎮炎液に1.0%の食塩を加え細菌
および真菌に対して細菌抑止および殺菌効果を調べた。
即ち、表記菌を肉汁培養液で培養し、夫夫の菌液各0.
1mlと1.0%の食塩を加えた洗浄液0.9mlを混
和して鎮炎液濃度として90%とし、室温で2分間処理
した後に残存している菌数をコロニー形成により調べ
た。結果は表2に示すように、いずれの菌も完全に不活
性化されたことが確認される。
Further, 1.0% sodium chloride was added to the anti-inflammatory solution, and the bacterial inhibition and bactericidal effects against bacteria and fungi were examined.
That is, the indicated bacteria were cultivated in a broth culture solution, and each of the bacteria solutions of the husband and wife was 0.
1 ml and 0.9 ml of a washing solution containing 1.0% sodium chloride were mixed to adjust the concentration of the anti-inflammatory solution to 90%, and after treatment at room temperature for 2 minutes, the number of remaining bacteria was examined by colony formation. As shown in Table 2, the results confirm that all the bacteria were completely inactivated.

【表2】 食塩を含む鎮炎液の殺菌効果 細菌、真菌名 生菌数/ml 未処理 2分処理 ブドー球菌 108.4 <100 細菌 レンサ球菌 108.2 <100 大腸菌 109.0 <100 緑膿菌 108.8 <100 枯草菌 106.0 <100 真菌 キャンデーダ 108.2 <100 [Table 2] Bactericidal effect of anti-inflammatory solution containing salt Bacteria, fungus Nominal number of bacteria / ml Untreated 2-minute treatment Budococcus 10 8.4 <10 0 bacteria Streptococcus 10 8.2 <10 0 Escherichia coli 10 9.0 <10 0 Pseudomonas aeruginosa Fungus 10 8.8 <10 0 Bacillus subtilis 10 6.0 <10 0 Fungus Candida 10 8.2 <10 0

【0017】[0017]

【実施例】図1は本発明に関わる鎮炎液生成装置の説明
図である。図において、電解槽4へ流入する市水の流量
を制御する弁体1などで流量を制御された市水電解槽4
直前に置かれた電解質供給手段3からNaCl、KCl
等の電解質が所定量添加され電解槽4に入る。電解槽4
はイオン透過性隔膜41で分割され、陰電極を挿入した
陰極室42と陽電極を挿入した陽極室43との陰陽電極
間に直流電圧を印加するように構成され、また、図示し
ない電解槽の電解強度を可変する印加電圧可変手段を設
けられている。尚、弁体1と電解質供給手段3との間に
濾過装置を置いてもよい。濾過装置は、例えば、中空糸
のようなある粒子以上の汚濁物質や細菌等を阻止するの
に適合する部材や活性炭およびそれらの組合せで構成さ
れ、所定以上の粒子径の物質や有害な物質は除去され
る。電解槽の陽極室43を出た吐水、つまり、酸化電位
水は所定のORP、pH等が酸化還元電位計、水素イオ
ン濃度計等のセンサ手段5で確認され、所定の範囲にあ
るときは逆止弁11を介してタンク6に流入する。
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS FIG. 1 is an explanatory view of an anti-inflammatory solution producing apparatus according to the present invention. In the figure, the city water electrolysis tank 4 whose flow rate is controlled by a valve body 1 for controlling the flow rate of city water flowing into the electrolysis cell 4
From the electrolyte supply means 3 placed immediately before, NaCl, KCl
A predetermined amount of electrolyte such as is added to the electrolytic bath 4. Electrolyzer 4
Is divided by the ion-permeable diaphragm 41, and is configured to apply a DC voltage between the cathode and cathode electrodes 42 and 43 having the cathode and anode electrodes inserted therein and the anode and anode electrodes 43, respectively. Applied voltage varying means for varying the electrolytic strength is provided. A filtration device may be placed between the valve body 1 and the electrolyte supply means 3. The filtration device is composed of, for example, a member suitable for blocking pollutants such as hollow fibers or particles having a certain particle size or bacteria, activated carbon, and a combination thereof. To be removed. The water discharged from the anode chamber 43 of the electrolytic cell, that is, the oxidation potential water, has a predetermined ORP, pH and the like confirmed by the sensor means 5 such as a redox potential meter and a hydrogen ion concentration meter. It flows into the tank 6 via the stop valve 11.

【0018】電解槽への供給水量、電解液供給手段3へ
の電解質の供給量、電解槽の陰陽極印加電圧等が適切な
値であるかは陽極室から吐出する酸化電位水を測定する
センサ手段5のORPおよびpHの値から知ることがで
きる。酸化電位水の所定値がORP900mv以上、p
H3.0以下の場合、混入タンク6に給水する。それ以
外の値のものは三方弁12から排水される。また、陰極
室から吐水される陰極水も排水される。好ましい状態で
吐出する酸化電位水は通常、ORP950〜1090m
v程度、pH2.8以下を示し、不光透過性瓶などに保
存されたものは比較的に安定で、本発明の鎮炎液として
機能する。また、所望によって、混入タンク6に0〜1
%程度食塩を加えて生理食塩含有の鎮炎液としてもよ
い。
Whether or not the amount of water supplied to the electrolytic cell, the amount of electrolyte supplied to the electrolytic solution supplying means 3, the voltage applied to the negative and positive electrodes of the electrolytic cell, etc. are appropriate values is a sensor for measuring the oxidation potential water discharged from the anode chamber. It can be known from the ORP and pH values of the means 5. Predetermined value of oxidation potential water is ORP 900 mv or more, p
In the case of H3.0 or less, water is supplied to the mixing tank 6. Any other value is drained from the three-way valve 12. In addition, the cathode water discharged from the cathode chamber is also drained. Oxidation potential water discharged in a preferable state is usually ORP950 to 1090 m.
Those having a pH of about 2.8 or less and a pH of 2.8 or less and stored in a non-light-transmitting bottle are relatively stable and function as the anti-inflammatory solution of the present invention. In addition, if desired, the mixing tank 6 may have 0 to 1
It is also possible to add about% sodium chloride to form a physiological saline-containing anti-inflammatory solution.

【0019】図1において、10は制御手段であって電
解槽の給水量、電解質供給手段の電解質供給量、電解印
加電圧等をセンサ手段5からのデータに基づきORP、
pHが規格範囲内に入るように自動的に制御するもので
ある。即ち、制御手段の一部を構成するROMに所望す
る値を入力しておけば、センサ手段5からのデータに基
づき比較回路が働き所望する範囲に電解槽の給水量、電
解質供給手段の電解質供給量、電解印加電圧等を制御す
ることができる。
In FIG. 1, reference numeral 10 is a control means which controls the amount of water supplied to the electrolytic cell, the amount of electrolyte supplied by the electrolyte supply means, the electrolytic applied voltage, etc. based on the data from the sensor means 5, ORP,
The pH is automatically controlled so that it falls within the standard range. That is, if a desired value is input to the ROM that constitutes a part of the control means, the comparison circuit operates based on the data from the sensor means 5 and the amount of water supplied to the electrolytic cell and the electrolyte supply of the electrolyte supply means are within a desired range. The amount, the voltage applied to the electrolysis, and the like can be controlled.

【0020】また、センサ手段8はORPを計測する手
段で、この手段からの情報に基づき、タンク6内部の酸
化電位水が前記したORPを示さないときは、ドレン9
を介して排水することができる。酸化電位水は経時と共
にORPが低下する。従って、既に使用した鎮炎液がタ
ンク6内部に残存している場合、その殺菌能力は低下し
ている虞れがある。これも、前記同様に制御手段10に
よって自動的に排除することが可能である。
The sensor means 8 is a means for measuring the ORP. Based on the information from this means, when the oxidation potential water in the tank 6 does not indicate the above-mentioned ORP, the drain 9 is used.
Can be drained through. Oxidation potential water decreases ORP with time. Therefore, when the anti-inflammatory liquid that has already been used remains inside the tank 6, there is a possibility that the sterilizing ability thereof may be reduced. This can also be automatically eliminated by the control means 10 as in the above.

【0021】上記の鎮炎液を乳房炎を発病した乳牛に注
入した場合の例を示す。すでに乳房炎を発病し乳房にし
こりができ、飼料の食欲が低下した廃牛に近い乳牛の乳
房の乳房炎症状を発した対応する乳頭より、pH2.
6、ORP1080mvの鎮炎液を朝、夕2回各500
〜600mlを注入器で注入し20〜30分放置後、搾
乳と同じ動作により鎮炎液を搾出させ、一旦乳房中の鎮
炎液を搾出させた後、改めてpH2.6、ORP108
0mvの鎮炎液を注入器で注入した。同じ行為を二日間
に亘って行った。まず、しこりがとれ、三日後には細菌
学的試験に異常がなく、牛乳の細胞数も平常値に戻っ
た。尚、注入量は上記した数値にとどまらず、乳線内に
飽和するまで注入してよい。また、鎮炎液の注入/搾出
は必ずしも一回に限定する必要はなく、搾出した鎮炎液
のORPを確認して900mvに達するまで繰り返すこ
とが好ましい。
An example of injecting the above anti-inflammatory solution into a dairy cow having mastitis will be described. From a corresponding teat that had mastitis symptoms in the udder of a dairy cow, which was close to abandoned cows that had already developed mastitis and had a lump in the udder and had a reduced appetite for feed, pH 2.
6. ORP 1080mv anti-inflammatory solution 500 times twice in the morning and evening
After injecting ~ 600 ml with an injector and leaving it for 20 to 30 minutes, the anti-inflammatory solution is squeezed out by the same operation as the milking, and once the anti-inflammatory solution in the breast is squeezed out, pH is 2.6 again, ORP108.
0 mV anti-inflammatory solution was injected with a syringe. I did the same thing for two days. First, the lump was removed, and after three days, there was no abnormality in the bacteriological test, and the number of milk cells returned to the normal value. The injection amount is not limited to the above-mentioned values, and may be injected until the milk line is saturated. Further, the injection / squeeze of the anti-inflammatory solution is not necessarily limited to one time, and it is preferable to repeat it until 900 mv is reached after confirming the ORP of the expressed anti-inflammatory solution.

【0022】急性乳房炎を発病し、発熱した乳牛の乳房
の1/4本に生成後1時間を経た食塩0.9%を含む鎮
炎液を朝、夕、朝と3回各1000mlを注入器で注入
した。翌朝には下熱し食欲旺盛となり、乳牛は急性乳房
炎時認められた不快症状が認められなくなり搾乳できる
状態となり、乳汁はPLテスタの計測で正常値にもどっ
た。この状態で採取した乳汁中に鎮炎液は認められず、
また、採取した乳に有機性の添加剤、抗生物質などの痕
跡も認められなかった。食塩を含む鎮炎液は殺菌性のあ
る生理食塩水と同等と理解され、乳線管から筋上皮細胞
を逆浸透し、乳線胞へと泌乳に逆らって細菌感染患部を
湿潤させ、好結果を得るものである。
1000 ml each of an anti-inflammatory solution containing 0.9% of salt that had been produced for 1 hour after injection was injected into ¼ of the udder of a cow with acute mastitis and fever, three times each in the morning, evening and morning. Injected with a container. The next morning, he became sick and had a strong appetite, and the dairy cows were free from the discomfort observed during acute mastitis and were ready for milking. The milk level returned to the normal level as measured by the PL tester. No anti-inflammatory solution was found in the milk collected in this state,
No traces of organic additives, antibiotics, etc. were found in the collected milk. An anti-inflammatory solution containing salt is understood to be equivalent to bactericidal physiological saline, reversely osmosis myoepithelial cells from the mammary duct, moisten the bacterial infected area against lactation against lactation, and produce good results. Is what you get.

【0023】急性乳房炎を発病した山羊の乳頭から食塩
0.3%を含む鎮炎液を200ml注入器で注入した。
翌朝には解熱した。搾乳も平常に行うことができた。
A 200 ml syringe was used to inject an anti-inflammatory solution containing 0.3% salt from the teat of a goat suffering from acute mastitis.
The next morning I had a fever. Milking could be done normally.

【0024】図2は注入施行図である。例えば、乳牛の
乳頭に容器16中の鎮炎液を細管17を介して注入管1
8から注入する。前記注入器として、例えば、点滴注入
器のような重力滴下型容器を用い、細管を乳頭に挿入し
て、容器16の位置を矢示の如くに上下させ、搾乳直後
の乳房に所定の量の鎮炎液を注入するが、容器16を加
圧型としてもよい。また、注入管18径は動物の種類な
どによって径、長さは適宜選択される。
FIG. 2 is an injection execution diagram. For example, the anti-inflammatory solution in the container 16 is injected into the teat of a dairy cow through the thin tube 17 and the injection tube
Inject from 8. As the injector, for example, a gravity drip type container such as a drip injector is used, a thin tube is inserted into the teat, and the position of the container 16 is moved up and down as shown by an arrow so that a predetermined amount of the milk can be applied to the breast immediately after milking. Although the quenching liquid is injected, the container 16 may be of a pressure type. Further, the diameter and the length of the injection tube 18 are appropriately selected depending on the type of animal.

【0025】酸化電位水を家畜の乳房洗浄液として使用
し、乳房や乳頭表皮を洗浄、殺菌することにより乳房炎
の発生予防と早期治療並びに細菌による表皮の感染を阻
止することができる。これらは例示にすぎず、以上説明
した実施例以外にも本発明の枠を逸脱しない範囲内で各
種の変形実施が可能である。
[0025] Oxidizing potential water can be used as a lavage fluid for livestock to wash and sterilize the udder and nipple epidermis to prevent and treat mastitis at an early stage and to prevent bacterial epidermal infection. These are merely examples, and various modifications can be made within the scope of the present invention other than the embodiments described above.

【0026】[0026]

【発明の効果】鎮炎液はウイルスや細菌、真菌等を死滅
する効果があり、また、血液、体液、膿等の水溶解性物
質に浸透・溶解する性質がある。鎮炎液を乳頭を介して
乳房の乳線管から筋上皮細胞を逆浸透し、乳線胞へと泌
乳に逆らって細菌感染患部に所定量注入することにより
乳房炎の原因となる細菌を死滅することができる。
INDUSTRIAL APPLICABILITY The anti-inflammatory solution has the effect of killing viruses, bacteria, fungi and the like, and has the property of penetrating and dissolving in water-soluble substances such as blood, body fluid and pus. Kill the bacteria that cause mastitis by reversely osmoticizing myoepithelial cells from the mammary duct of the breast through the nipple and injecting a predetermined amount into the affected area of the mammary vesicle against lactation. can do.

【0027】乳房への注入は乳頭から注入管をもって、
乳線管から筋上皮細胞を逆浸透し、乳線胞へと泌乳に逆
らって患部を湿潤させるという簡単な方法で行うことが
できるので乳牛に何ら損傷を与えない。
For injection into the breast, with an injection tube from the nipple,
It does not cause any damage to the cow because it can be done in a simple way by reverse osmosis of the myoepithelial cells from the milk duct to moisturize the affected area against lactation into the mammary tract.

【0028】乳房に鎮炎液が残留しているかの判断は搾
乳の乳汁が無色から乳白色へ変色することから容易に知
ることができるので、鎮炎液の再注入の時間判断が的確
に行える。
The determination of whether or not the anti-inflammatory solution remains in the breast can be easily known from the fact that the milk of milking changes from colorless to milky white, and therefore the time for re-injection of the anti-inflammatory solution can be accurately determined.

【0029】鎮炎液には殺菌性のある薬剤や抗生物質の
ような残留性のある物質を含まぬため、治癒後の牛乳中
に有害な物質が含有しない。即ち、鎮炎液は経時と共に
ORPが低下し残留性がなく、しかも、安価に供給でき
る。
Since the anti-inflammatory solution does not contain residual substances such as bactericidal drugs and antibiotics, no harmful substances are contained in the cured milk. That is, the anti-inflammatory solution has a low ORP with time, has no residual property, and can be supplied at a low cost.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は本発明に関わる鎮炎液生成装置の説明図
である。
FIG. 1 is an explanatory diagram of an anti-inflammatory liquid generator according to the present invention.

【図2】図2は注入施行図である。FIG. 2 is an injection procedure diagram.

【符号の説明】[Explanation of symbols]

1 弁体 3 電解質供給手段 4 電解槽 5 センサ手段 8 センサ手段 9 ドレン 10 制御手段 11 逆止弁 12 三方弁 16 容器 17 細管 18 注入管 DESCRIPTION OF SYMBOLS 1 Valve body 3 Electrolyte supply means 4 Electrolyzer 5 Sensor means 8 Sensor means 9 Drain 10 Control means 11 Check valve 12 Three-way valve 16 Container 17 Capillary tube 18 Injection pipe

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 電解槽直前に置かれた電解質供給手段か
ら添加された電解質を流入し、イオン透過性隔膜で分割
され、陰電極を挿入した陰極室と陽電極を挿入した陽極
室との陰陽電極間に直流電圧を印加し、電解槽の電解強
度を可変する印加電圧可変手段を設け、電解槽に流入し
た原水を電解する装置で生成した酸化電位水を有蹄類の
乳房に注入することにより鎮炎液として乳房炎を鎮炎す
ることを特徴とする有蹄類乳房炎の鎮炎方法。
1. A positive and negative electrode chamber in which an electrolyte added from an electrolyte supply means placed immediately before the electrolytic cell is introduced and divided by an ion-permeable diaphragm, and a cathode chamber in which a negative electrode is inserted and an anode chamber in which a positive electrode is inserted are formed. Applying a DC voltage between the electrodes and providing means for varying the applied voltage to vary the electrolytic strength of the electrolyzer, and injecting oxidative potential water generated by the device that electrolyzes the raw water that has flowed into the electrolyzer into the breasts of ungulates A method for suppressing ungulate mastitis, which comprises suppressing mastitis as an anti-inflammatory solution according to.
【請求項2】 前記乳房への注入は乳頭から注入管をも
って注入し、乳線管から筋上皮細胞を逆浸透し、乳線胞
へと泌乳に逆らって細菌感染患部を湿潤させることを特
徴とする請求項1記載の有蹄類乳房炎の鎮炎方法。
2. The injection into the breast is performed by injecting from the nipple with an injection tube, reversely osmosis myoepithelial cells from the milk duct, and moisten a bacterial infection affected area against lactation against lactation. The method for quenching ungulate mastitis according to claim 1.
【請求項3】 前記鎮炎液はpH2.5〜3.0、OR
P900〜1100mvである請求項1記載の有蹄類乳
房炎の鎮炎液。
3. The anti-inflammatory solution has a pH of 2.5 to 3.0 and OR.
The anti-inflammatory solution for ungulate mastitis according to claim 1, which has a P900 to 1100 mv.
【請求項4】 前記鎮炎液はpH2.5〜3.0、OR
P900〜1100mvで、食塩0〜1%を含有する請
求項1記載の有蹄類乳房炎の鎮炎液。
4. The anti-inflammatory solution has a pH of 2.5 to 3.0 and OR.
The anti-inflammatory solution for ungulate mastitis according to claim 1, which contains 0 to 1% of salt at P900 to 1100 mv.
JP08920594A 1994-04-05 1994-04-05 Anti-inflammatory method and anti-inflammatory solution for ungulate mastitis Expired - Fee Related JP3680125B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP08920594A JP3680125B2 (en) 1994-04-05 1994-04-05 Anti-inflammatory method and anti-inflammatory solution for ungulate mastitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP08920594A JP3680125B2 (en) 1994-04-05 1994-04-05 Anti-inflammatory method and anti-inflammatory solution for ungulate mastitis

Publications (2)

Publication Number Publication Date
JPH07277996A true JPH07277996A (en) 1995-10-24
JP3680125B2 JP3680125B2 (en) 2005-08-10

Family

ID=13964223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP08920594A Expired - Fee Related JP3680125B2 (en) 1994-04-05 1994-04-05 Anti-inflammatory method and anti-inflammatory solution for ungulate mastitis

Country Status (1)

Country Link
JP (1) JP3680125B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335142A (en) * 1998-03-13 1999-09-15 Color Access Inc Pharmaceutical compositions comprising I and S structured water
GB2335141A (en) * 1998-03-13 1999-09-15 Color Access Inc Pharmaceutical compositions comprising structured S water

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2335142A (en) * 1998-03-13 1999-09-15 Color Access Inc Pharmaceutical compositions comprising I and S structured water
GB2335141A (en) * 1998-03-13 1999-09-15 Color Access Inc Pharmaceutical compositions comprising structured S water
FR2775898A1 (en) * 1998-03-13 1999-09-17 Color Access Inc STRUCTURED WATER IN COSMETIC COMPOSITIONS
GB2335142B (en) * 1998-03-13 2000-05-17 Color Access Inc Structured water in cosmetic compositions
GB2335141B (en) * 1998-03-13 2000-05-17 Color Access Inc Structured water for enhanced moisturization
US6139855A (en) * 1998-03-13 2000-10-31 Color Access, Inc. Structured water in cosmetic compositions
US6231874B1 (en) 1998-03-13 2001-05-15 Color Access, Inc. Structured water for enhanced moisturization

Also Published As

Publication number Publication date
JP3680125B2 (en) 2005-08-10

Similar Documents

Publication Publication Date Title
CN1816330B (en) Antiseptic compositions, methods and systems
CN1289095C (en) Physiologically balanced ionized acidic solution and methodology for use in wound healing
JPH08252310A (en) Washing and disinfecting method of artificial dialyzing device using electrolytically generated acidic water, and device therefor
US20030185704A1 (en) Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
JPS60197289A (en) Sterilized water and method and device for forming sterilized aqueous solution
JPH02193905A (en) Hygienic agent for hemodialysis
CN104958830A (en) Subacid electrolyzed oxidizing water gynecological anti-infection treatment facility
US20180343853A1 (en) Antimicrobial solid and method of making same
JP2015104719A (en) Production method of weakly-acidic hypochlorous acid aqueous solution
Rani et al. Irrigation with N, N-dichloro-2, 2-dimethyltaurine (NVC-422) in a citrate buffer maintains urinary catheter patency in vitro and prevents encrustation by Proteus mirabilis
JPH07277996A (en) Method for soothing inflammation of mastitis in ungulata and antiinflammatory solution
DE202011105738U1 (en) Online disinfection by means of diamond electrolysis of dialysis machines
JP5405736B2 (en) Dialysis aqueous solution
CN107412257B (en) Medicated bath agent for nipples of dairy cows as well as preparation method and application of medicated bath agent
JP3239251B2 (en) Cleaning liquid generator and cleaning liquid
EP1257301B1 (en) Medical device disinfection
JPH08649A (en) Tait cup and inflammation-suppressive liquid also used for cleaning nipple
JP2000246251A (en) Electrolyzed water forming apparatus, medical care tool, sterilizing agent and method for sterilization
JPH07277995A (en) Cleaning solution for inside of uterus of milk cow and cleaning method
CN102488908B (en) Flushing fluid for electrocision and application of same
JP6931256B2 (en) Disinfectants for Legionella spp., Water treatment methods, bath water additives, and air conditioning cooling tower water additives
Ekmekçioğlu et al. Electrified urinary drainage bag: an in vitro study
RU2246323C2 (en) Method for curative sounding
RU2249466C2 (en) Disinfectant
RU2636330C1 (en) Method for disinfecting udder and teats of animals of dairy breed

Legal Events

Date Code Title Description
RD13 Notification of appointment of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7433

Effective date: 20040506

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20041004

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20041004

A072 Dismissal of procedure

Effective date: 20050201

Free format text: JAPANESE INTERMEDIATE CODE: A073

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20050412

A61 First payment of annual fees (during grant procedure)

Effective date: 20050421

Free format text: JAPANESE INTERMEDIATE CODE: A61

R150 Certificate of patent (=grant) or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees